Incidence of acute peripheral neurotoxicity after deep regional hyperthermia of the pelvis

References

• Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0. 2003, http://ctep.cancer.gov
   Google Scholar
• Fatehi D, De Bruijne M, Van der Zee J, Van Rhoon GC. RHyThM, a tool for analysis of PDOS formatted hyperthermia treatment data generated by the BSD2000/3D system. Int J Hyperthermia 2006; 22: 173–184
   PubMed Web of Science ®Google Scholar
• Fatehi D, Van der Zee J, De Bruijne M, Franckena M, Van Rhoon GC. RF-power and temperature data analysis of 444 patients with primary cervical cancer: Deep hyperthermia using the Sigma-60 applicator is reproducible. Int J Hyperthermia 2007; 23: 623–643
   PubMed Web of Science ®Google Scholar
• Denton AS, Bond SJ, Matthews S, Bentzen SM, Maher EJ. and the UK Link Gynaecology-Oncology Group. National Audit of the management and outcome of carcinoma of the cervix treated with radiotherapy in 1993. Clin Oncol 2000; 12: 347–353
   PubMed Web of Science ®Google Scholar
• Eifel PJ, Levenback C, Wharton T, Oswald MJ. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1995; 32: 1289–1300
   PubMed Web of Science ®Google Scholar
• Perez CA, Grigsby PW, Lockett MA, Chao KSC. Radiation therapy morbidity in carcinoma of the uterine cervix: Dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys 1999; 44: 855–866
   PubMed Web of Science ®Google Scholar
• Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL, Walker JL, Gersell D. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999; 340: 1154–1161
   PubMed Web of Science ®Google Scholar
• Pearcey R, Brundage M, Drouin P, Jeffrey J, Johnston D, Lukka H, MacLean G, Souhami L, Stuart G, Tu D. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell carcinoma of the cervix. J Clin Oncol 2002; 20: 966–972
   PubMed Web of Science ®Google Scholar
• Haveman J, Van der Zee J, Wondergem J, Hoogeveen JF, Hulshof MCCM. Effects of hyperthermia on the peripheral nervous system: A review. Int J Hyperthermia 2004; 20: 371–391
   PubMed Web of Science ®Google Scholar
• Busse O, Aigner K, Wilimzig H. Peripheral nerve damage follosing isolated extremity perfusion with cis-platinum. Recent Results Cancer Res 1983; 86: 264–267
   PubMedGoogle Scholar
• Kettelhack C, Kraus T, Hupp T, Manner M, Schlag P. Hyperthermia limb perfusion for malignant melanoma and soft tissue sarcoma. Eur J Surg Oncol 1990; 16: 370–375
   PubMed Web of Science ®Google Scholar
• Hoogeveen JF, Van der Kracht AHW, Wondergem J, Gonzalez Gonzalez D, Haveman J. Influence of cisplatin on the sensitivity of the rat sciatic nerve to local hyperthermia. Neurotoxicology 1993; 14: 1–7
   PubMed Web of Science ®Google Scholar
• Haveman J, Wondergem J, Van Dam WM, Van der Kracht AHW. Irradiation of the rat sciatic nerve leads to delayed recovery from function loss after heat treatment or mechanical damage. Neurosci Res Comm 1994; 14: 1–7
   Google Scholar
• Vujaskovic Z, Gillette SM, Powers BE, Stukel TA, Larue SM, Gillette EL, Borak TB, Scott RJ, Weiss J, Colacchio TA. Effects of intraoperative irradiation and intraoperative hyperthermia on canine sciatic nerve: Neurologic and electrophysiologic study. Int J Radiat Oncol Biol Phys 1996; 34: 125–131
   PubMed Web of Science ®Google Scholar
• Hoogeveen JF, Van der Kracht AHW, Wondergem J, Haveman J. Effects of local hyperthermia on the sensitivity of rat sciatic nerve from diabetic rats. Neurosci Res Comm 1993; 12: 63–70
   Google Scholar
• Sreenivasa G, Gellermann J, Rau B, Nadobny J, Schlag P, Dueflhard P, Felix R, Wust P. Clinical use of the hyperthermia treatment planning system Hyperplan to predict effectiveness and toxicity. Int J Radiat Oncol Biol Phys 2003; 55: 407–419
   PubMed Web of Science ®Google Scholar
• Gellermann J, Göke J, Figiel R, Weihrauch M, Cho CH, Budach V, Felix R, Wust P. Simulation of different applicator positions for treatment of a presacral tumour. Int J Hyperthermia 2007; 23: 37–47
   PubMed Web of Science ®Google Scholar
• Gellermann J, Wust P, Stalling D, Seebass M, Nadobny J, Beck R, Hege H-C, Deuflhard P, Felix R. Clinical evaluation and verification of the hyperthermia treatment planning system Hyperplan. Int J Radiat Oncol Biol Phys 2000; 47: 1145–1156
   PubMed Web of Science ®Google Scholar
• Van Haaren PMA, Kok HP, Van den Berg CAT, Zum Vorde sive Vörding PJ, Oldenburg S, Stalpers LJA, Schilthuis MS, De Leeuw AC, Crezee J. On verification of hyperthermia treatment planning for cervical cancer patients. Int J Hyperthermia 2007; 23: 303–314
   PubMed Web of Science ®Google Scholar
• Gellermann J, Wlodarczyk W, Feussner A, Fähling H, Nadobny J, Hildebrandt B, Felix R, Wust P. Methods and potentials of magnetic resonance imaging for monitoring radiofrequency hyperthermia in a hybrid system. Int J Hyperthermia 2005; 21: 497–513
   PubMed Web of Science ®Google Scholar
• Wust P, Cho CH, Hildebrandt B, Gellermann J. Thermal monitoring: Invasive, minimal-invasive and non-invasive approaches. Int J Hyperthermia 2006; 22: 255–262
   PubMed Web of Science ®Google Scholar
• Van der Zee J, González González D, Van Rhoon GC, Van Dijk JDP, Van Putten WLJ, Hart AAM. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Lancet 2000; 355: 1119–1125
   PubMed Web of Science ®Google Scholar